Male genital lichen planus: A retrospective study of 89 cases.


Journal

Annales de dermatologie et de venereologie
ISSN: 0151-9638
Titre abrégé: Ann Dermatol Venereol
Pays: France
ID NLM: 7702013

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 17 12 2020
revised: 12 03 2021
accepted: 15 04 2021
pubmed: 6 7 2021
medline: 23 2 2022
entrez: 5 7 2021
Statut: ppublish

Résumé

Unlike other types of lichen planus (LP), there are no series concerning male genital LP. To describe the clinical characteristics, diagnosis, and response to treatment of male genital LP. A retrospective study of male patients with genital LP consulting a dermatologist specialized in anogenital diseases between January 2010 and 2019. Demographic data, history, functional signs, clinical characteristics, pathology, complications, and treatment efficacy were collected. Eighty-nine patients were included at four centers. The median age was 51 years. Most patients were uncircumcised and asymptomatic. In 88.8% of cases, only the genital mucosa was involved. Erythema (71%), papules (21.3%), lacy network (15.7%), atrophic lesions (15.7%), erosions (14.6%), and post-inflammatory hyperpigmentation (2.2%) were less frequently observed. Biopsy results confirmed LP in 61.3% of cases but could not rule out other inflammatory genital dermatoses in other cases. Anatomic complications were observed in 30.3% of patients. Topical corticosteroids (TCS) induced remission in most cases. Tacrolimus efficacy was comparable to that of TCS. Male genital LP is a rare inflammatory disorder chiefly affecting uncircumcised men. It is found predominantly on the mucosal component of the penis and presents as non-erosive inflammatory balanitis in most cases, with frequent partial or complete remission on treatment with TCS.

Sections du résumé

BACKGROUND BACKGROUND
Unlike other types of lichen planus (LP), there are no series concerning male genital LP.
OBJECTIVE OBJECTIVE
To describe the clinical characteristics, diagnosis, and response to treatment of male genital LP.
PATIENTS AND METHODS METHODS
A retrospective study of male patients with genital LP consulting a dermatologist specialized in anogenital diseases between January 2010 and 2019. Demographic data, history, functional signs, clinical characteristics, pathology, complications, and treatment efficacy were collected.
RESULTS RESULTS
Eighty-nine patients were included at four centers. The median age was 51 years. Most patients were uncircumcised and asymptomatic. In 88.8% of cases, only the genital mucosa was involved. Erythema (71%), papules (21.3%), lacy network (15.7%), atrophic lesions (15.7%), erosions (14.6%), and post-inflammatory hyperpigmentation (2.2%) were less frequently observed. Biopsy results confirmed LP in 61.3% of cases but could not rule out other inflammatory genital dermatoses in other cases. Anatomic complications were observed in 30.3% of patients. Topical corticosteroids (TCS) induced remission in most cases. Tacrolimus efficacy was comparable to that of TCS.
CONCLUSION CONCLUSIONS
Male genital LP is a rare inflammatory disorder chiefly affecting uncircumcised men. It is found predominantly on the mucosal component of the penis and presents as non-erosive inflammatory balanitis in most cases, with frequent partial or complete remission on treatment with TCS.

Identifiants

pubmed: 34218935
pii: S0151-9638(21)00056-9
doi: 10.1016/j.annder.2021.04.007
pii:
doi:

Substances chimiques

Glucocorticoids 0
Tacrolimus WM0HAQ4WNM

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

28-31

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

J Amsellem (J)

Dermatology Department, Robert-Ballanger Hospital, boulevard Robert-Ballanger, 93600 Aulnay-sous-Bois, France.

C Skayem (C)

Faculté de médecine, université de Paris, 15, rue de l'École de Médecine, 75006 Paris, France; Dermatology Department, Henri-Mondor University Hospital, AP-HP, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France.

T-A Duong (TA)

Dermatology Department, Henri-Mondor University Hospital, AP-HP, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France.

M Bagot (M)

Faculté de médecine, université de Paris, 15, rue de l'École de Médecine, 75006 Paris, France; Dermatology Department, Saint-Louis University Hospital, AP-HP, 1, avenue Claude-Vellefaux, 75010 Paris, France.

S Fouéré (S)

Dermatology Department, Saint-Louis University Hospital, AP-HP, 1, avenue Claude-Vellefaux, 75010 Paris, France.

J-N Dauendorffer (JN)

Dermatology Department, Saint-Louis University Hospital, AP-HP, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: jn.dauendorffer@orange.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH